Andrianopoulos N - Search Results

1

Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry.

Ajani AE, Reid CM, Duffy SJ, Andrianopoulos N, Lefkovits J, Black A, New G, Lew R, Shaw JA, Yan BP, Gurvitch R, Al-Fiadh A, Brennan AL, Clark DJ. Ajani AE, et al. Among authors: andrianopoulos n. Med J Aust. 2008 Oct 20;189(8):423-8. doi: 10.5694/j.1326-5377.2008.tb02113.x. Med J Aust. 2008. PMID: 18928433

2

Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction.

Gurvitch R, Lefkovits J, Warren RJ, Duffy SJ, Clark DJ, Eccleston D, Yan BP, Reid C, Brennan A, Andrianopoulos N, Ajani AE. Gurvitch R, et al. Among authors: andrianopoulos n. Int J Cardiol. 2010 Sep 3;143(3):283-8. doi: 10.1016/j.ijcard.2009.03.064. Epub 2009 Apr 2. Int J Cardiol. 2010. PMID: 19344962

3

Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspective.

Brennan AL, Andrianopoulos N, Duffy SJ, Reid CM, Clark DJ, Loane P, New G, Black A, Yan BP, Brooks M, Roberts L, Carroll EA, Lefkovits J, Ajani AE; Melbourne Interventional Group Investigators. Brennan AL, et al. Among authors: andrianopoulos n. Intern Med J. 2014 May;44(5):471-7. doi: 10.1111/imj.12405. Intern Med J. 2014. PMID: 24606571

4

Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.

Yudi MB, Eccleston D, Andrianopoulos N, Farouque O, Duffy SJ, Brennan A, Reid C, Clark DJ, Ajani AE; Melbourne Interventional Group. Yudi MB, et al. Among authors: andrianopoulos n. Intern Med J. 2015 Oct;45(10):1032-7. doi: 10.1111/imj.12818. Intern Med J. 2015. PMID: 26013065

5

Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Yudi MB, Clark DJ, Farouque O, Eccleston D, Andrianopoulos N, Duffy SJ, Brennan A, Lefkovits J, Ramchand J, Yip T, Oqueli E, Reid CM, Ajani AE; Melbourne Interventional Group. Yudi MB, et al. Among authors: andrianopoulos n. Intern Med J. 2016 May;46(5):559-65. doi: 10.1111/imj.13041. Intern Med J. 2016. PMID: 26909472

6

An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry.

Yan BP, Gurvitch R, Duffy SJ, Clark DJ, Sebastian M, New G, Warren R, Lefkovits J, Lew R, Brennan AL, Reid C, Andrianopoulos N, Ajani AE. Yan BP, et al. Among authors: andrianopoulos n. Catheter Cardiovasc Interv. 2007 Dec 1;70(7):928-36. doi: 10.1002/ccd.21303. Catheter Cardiovasc Interv. 2007. PMID: 18044763

7

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.

Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ; Melbourne Interventional Group Investigators. Yan BP, et al. Among authors: andrianopoulos n. Int J Cardiol. 2008 Nov 28;130(3):374-9. doi: 10.1016/j.ijcard.2008.06.046. Epub 2008 Aug 15. Int J Cardiol. 2008. PMID: 18706719

8

Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.

Shaw JA, Andrianopoulos N, Duffy S, Walton AS, Clark D, Lew R, Sebastian M, New G, Brennan A, Reid C, Ajani AE; Melbourne Interventional Group. Shaw JA, et al. Among authors: andrianopoulos n. Cardiovasc Revasc Med. 2008 Oct-Dec;9(4):218-23. doi: 10.1016/j.carrev.2008.05.002. Cardiovasc Revasc Med. 2008. PMID: 18928945

9

Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.

Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM; Melbourne Interventional Group. Freeman M, et al. Among authors: andrianopoulos n. Catheter Cardiovasc Interv. 2009 May 1;73(6):763-8. doi: 10.1002/ccd.21941. Catheter Cardiovasc Interv. 2009. PMID: 19309731

10

The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.

Butler MJ, Eccleston D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan A, New G, Black A, Szto G, Reid CM, Yan BP, Shaw JA, Dart AM, Duffy SJ; Melbourne Interventional Group. Butler MJ, et al. Among authors: andrianopoulos n. Am Heart J. 2009 May;157(5):899-907. doi: 10.1016/j.ahj.2009.02.018. Am Heart J. 2009. PMID: 19376319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page